chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female who was vaccinated with pneumococcal 23v polysaccharide vaccine.  Subsequently the patient's arm hurt so much she could not sleep.  The patient went to the emergency room was given medicine, and sent home.  The patient recovered.  Additional information has been requested.
At night, chills and sweats began and fever of 101 took aspirin. On Wednesday symptoms on and off. Red blotch appeared 2 inches below injection sites, a streak appearred on one side. Today, doctor diagnosed it as phebotis type reaction. Red and hard in certain areas. Prescribed cephalexin for next 2 weeks. (500 mg, 3 x day)
Facial - lips swelling. Chills diarrhea dizzy headache - 24 hrs. 2 cc KENALOG - 40mg. Patient reports after inj. allergy to egg whites and had eggs for breakfast.
Started with pain in the abdomen and chest after sinusitis   Flammable throat started   The phlegm has already drained everything I had.  Without sinusitis   Only fever and sore throat   Fever.  sweating all night yet I'm using medicine for those sintomas
COVID-19 vaccination improperly diluted. The manufacturer recommended getting revaccinated. Patient made aware of the situation and recommendations.
Swelling of lymph node in left armpit; Heart palpitations; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Jan2022 13:30 (Lot number: FH8027) as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D3. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 10Feb2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 22Jan2021, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 29Jan2022, outcome "unknown", described as "Swelling of lymph node in left armpit"; PALPITATIONS (non-serious) with onset 29Jan2022, outcome "unknown", described as "Heart palpitations". The events "swelling of lymph node in left armpit" and "heart palpitations" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy, palpitations.   Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.    No follow-up attempts are possible. No further information is expected.
Pt reports fever of >105 F for several hours, reduced by acetaminophen.  States "felt like a zombie" and that his "head felt big and tight".  Symptoms currently resolved ( now ~22 hours post onset), no longer taking antipyretics, current temp 99.1 F.
R upper arm red, warm, swollen one day after DAPTACEL #5, MMR #2. BENADRYL, Ibuprofen.
Weak pulse (under 50 bpm); Weak pulse (under 50 bpm); heart palpitations/pounding; PVC on ECG; Dose Number: 3; This is a spontaneous report received from a contactable reporter (Consumer). A 40-year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 03Dec2021 (Batch/Lot number: unknown) at the age of 40 years as dose 3 (booster), single for covid-19 immunisation.  The patient's relevant medical history and concomitant medications were not reported.  Vaccination history included: Comirnaty (Dose Number: 1, Location of injection: Arm Left), administration date: 04Apr2021, when the patient was 39 years old, for Covid-19 immunization; Comirnaty (Dose Number: 2, Location of injection: Arm Left), for Covid-19 immunization.  The patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The following information was reported: PULSE ABNORMAL (medically significant), HEART RATE DECREASED (medically significant) all with onset 04Dec2021, outcome "recovering" and all described as "Weak pulse (under 50 bpm)"; IMMUNISATION (non-serious) with onset 03Dec2021, outcome "unknown", described as "Dose Number: 3"; PALPITATIONS (non-serious) with onset 04Dec2021, outcome "recovering", described as "heart palpitations/pounding"; VENTRICULAR EXTRASYSTOLES (non-serious) with onset 04Dec2021, outcome "recovering", described as "PVC on ECG". The events "weak pulse (under 50 bpm)", "weak pulse (under 50 bpm)", "heart palpitations/pounding" and "pvc on ecg" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: electrocardiogram (ECG): (04Dec2021) PVC; pulse: (04Dec2021) under 50 beats per minute (bpm), notes: Weak pulse.  Therapeutic measures were not taken as a result of pulse abnormal, palpitations, palpitations, ventricular extrasystoles. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 17-AUG-2016, the patient was vaccinated with an improperly stored dose of VARIVAX (lot # M000996, expiry date 07-JAN-2018, dose, strength, vaccination site, route unspecified). The vaccine was exposed to a temperature of 6.5 Fahrenheit (F) for 80 hours. Digital data logger was not involved. There was no previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
reported feeling of warmth over her right after injection and tingling sensation in arm & "anxious & nervous".  TX: mask removal ; opened car windows x 4 for air flow; emotional support for anxiety.
Patient received COVID Pfizer vaccine on 1/25/21 and 2/15/21. Pt became COVID + on 4/13/21. Pt admitted in the hospital on 4/19/21.
STINGING AT INJECTION SITE; CHILLS; COULD BARELY WALK TO KITCHEN; NAUSEA; HEADACHE; FEVER; FATIGUE; WEAKNESS; LITTLE SORENESS AT INJECTION SITE; MAYBE A LITTLE BIT OF MENTAL CONFUSION; NECK PAIN; FELT LETHARGIC; HUNGER; LAST NIGHT WAS OUT OF IT AND COULD NOT DO  ANYTHING; KNOCKED OUT FOR ABOUT 10 HOURS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included pass out when younger due to allergies, and tingling in mouth before pass out, and concurrent conditions included history of allergic reactions to many different things, and penicillin and erythromycin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 09:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced hunger. On APR-2021, the subject experienced last night was out of it and could not do anything. On APR-2021, the subject experienced knocked out for about 10 hours. On 12-APR-2021, the subject experienced maybe a little bit of mental confusion. On 12-APR-2021, the subject experienced neck pain. On 12-APR-2021, the subject experienced felt lethargic. On 12-APR-2021, the subject experienced could barely walk to kitchen. On 12-APR-2021, the subject experienced nausea. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced fatigue. On 12-APR-2021, the subject experienced weakness. On 12-APR-2021, the subject experienced little soreness at injection site. On 12-APR-2021 16:30, the subject experienced chills. On 13-APR-2021, the subject experienced stinging at injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stinging at injection site, was recovering from nausea, chills, maybe a little bit of mental confusion, little soreness at injection site, felt lethargic, and could barely walk to kitchen, had not recovered from headache, fever, fatigue, weakness, and neck pain, and the outcome of hunger, last night was out of it and could not do anything and knocked out for about 10 hours was not reported. This report was non-serious.
Immediately after nasal administration, sneezing, watery-swollen eyes, rhinorrhea stiff neck and clear runny nose and body aches. Tx: 1ml Celestone IM; Lopraric; Medrol Dose Pack.
Chills, fatigue, upset stomach, cramping, chemical taste in mouth Narrative: Chills, fatigue, upset stomach, cramping,  chemical taste in mouth; took tylenol.
She received the last dose in the series and about 12 hours after the dose was administered, patient started showing flu-like symptoms. Developed a low grade fever ranging from 100-101, persistent vomiting every 30 minutes, nausea, muscle aches and leg pain. The vomiting stopped after about 12 hours, the nausea and muscle aches lasted 2-3 days. Consulted with pediatrician over the phone and was advised small sips of water and follow-up the next day. As she was improving we were instructed to monitor her and call again if no improvement or worsening. Pediatrician said it was likely viral but nobody else in the household (19 month old and 2 adults) showed any symptoms. My wife and I are both pharmacists and strongly feel this is related to the dose administered. These types of symptoms are listed as possible side effects for 1-10% of patients and other pharmaceutical information software we maintain subscriptions to.
felt a little knot where they injected the needle/had a little mark or bump where he had the injection/Bump on my arm; I can feel it on my arm; This is a spontaneous report from a contactable consumer (patient) or other non hcp.   A 65-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) (Batch/Lot Number: EW6602) dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 as dose 2, single, dose 1 (Batch/Lot Number: EM9810) via an unspecified route of administration, administered in Arm Left on 04Feb2021 is dose 1, single (age at vaccination: 65-yesr-old) for COVID-19 immunization. Medical history included blood pressure high, cholesterol. Concomitant medication(s) included amlodipine (AMLODIPINE); rosuvastatin (ROSUVASTATIN) taken for hypertension, blood cholesterol increased, start and stop date were not reported; aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) (1x/day (Low dose Aspirin)) taken for an unspecified indication, start and stop date were not reported. Patient reported Weight (kg) as 104.33 and Height (cm) as 182. On unspecified date patient previously took Flu shots. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On Jul2021, patient experienced felt a little knot where they injected the needle/had a little mark or bump where he had the injection/bump on my arm; i can feel it on my arm, it's a bump on my arm, it doesn't hurt or anything. it is a bump on my arm that doesn't hurt but i can feel it on my arm. there was no treatment reported. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
OFF LABEL DOSING FREQUENCY; This spontaneous report received from a patient concerned a 70 year old female of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient had previously received covid-19 vaccine ad26.cov2.s (Dose number in series: 1) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose and start therapy date were not reported, 1 total administered for covid-19 prophylaxis. No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series: 1). The patient had previously received covid-19 vaccine ad26.cov2.s (Dose number in series: 2) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose and start therapy date were not reported, 1 total (first booster) administered for covid-19 prophylaxis. No adverse events were reported following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series: 2). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series: 3) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total (second booster) administered on 04-MAY-2022 for covid-19 prophylaxis which was off label dosing frequency (Dose number in series: 3), associated with an Off label use. Age at time of vaccination 70 years old. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of off label dosing frequency was not reported. This report was non-serious.
Seriousness: Other-Medically Significant Information received on 24 January 2008 from the above reference journal article in which a 2-year-old male patient had received their first Influenza vaccine (manufacturer and lot number not provided) and shortly thereafter, developed a few hives scattered on his body with no respiratory symptoms. The hives appeared intermittently and were treated occasionally with diphenhydramine. The patient subsequently received his Influenza booster vaccination one month later and within ten minutes of vaccination, starting having coughing, wheezing and hives all over his body. he was treated acutely with diphenhydramine and nebulized albuterol. Epinephrine was not given. The patient was referred for evaluation of his allergic reaction to influenza vaccine. His physician examination at the time of follow-up for an allergy evaluation was normal. The patient had no known allergies and was up to date with their vaccinations with no prior adverse events. The patient had a positive history for developing perioral hives associated with eating gummy candy fruit snacks and Hot Tamale candies. The patient had been able to eat eggs with no problems. Follow up allergy testing included a skin prick test with the following results: histamine 6/30 mm, saline 0/0 mm, Knox gelatin (mixed with saline) 3/15, and liquefied gummy fruit snack (1:1 dilution in saline) 6/25 mm. Serum was sent for IgE to specific antigens with the following results: 1g# 127 ku/L with RAST to bovine gelatin 4.50 (class 3). A diagnosis of gelatin allergy was concluded based on his history and confirmatory skin and RAST testing. Since his initial episode, the patient had inadvertant gelatin exposure with ingestion of Frosted Mini-Wheat cereal, bacon and lunch meats with subsequent allergic reactions. No further information was provided in the report.
First symptoms are bilateral shoulder pain & fatigue. Severe periodic abdominal pain, mild diarrhea, & headache stated on 10/22/12 & con't till today 10/25/12. PCP seen but provided little input.  Rx used to help (e.g. Donnatol, Loperamide, Norco) was of little help.  Morning severe generalized abdominal pain is intense, but gradually gets less as the day goes on.  It subsides in the evening, only to reappear the next morning.
felt like she was getting the flu; felt a little off for 2 days; This case was reported by a consumer and described the occurrence of influenza like illness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th July 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced influenza like illness and feeling abnormal. On an unknown date, the outcome of the influenza like illness and feeling abnormal were recovered/resolved.   It was unknown if the reporter considered the influenza like illness and feeling abnormal to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine in the left arm and she felt like was getting the flu and felt a little off for 2 days and then these reactions resolved. The patient did not had lot number or expiration date information to provide. For tolerance of 2nd dose of Shingrix, refer case US2020AMR229116, reported by same reporter. This case has been linked with US2020228560, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020228560:same reporter (sister´s case) US-GLAXOSMITHKLINE-US2020AMR229116:same reporter
all side effects still happening and have been for over a month breast pain    (have implants from 1999 and have hysterectomy since 15 years ago) weight gain fatigue infection in body, mostly in bladder area but at this point unidentified blood results all significantly off from recent CBC tests done in 2021   lymphocytes, monocytes, WBC high  RBC  low, sodium low  glucose high, basophils (have at least 4 results to compare to over past 6 months, cbc and chem panel)  low tsh headaches heart issues  tightness  hypertension  trouble breathing
Itchy feeling all over back and down arms. Feeling comes and goes. Feels like I'm wearing a very uncomfortable wool sweater.
After initial shot healed patient is left with a tiny bump on the skin of her arm in that spot. It looks like it wants to scab over, but it will not scab and remains a little bump at that injection site a year later.
Nerve issues, spinal issues, joint issues; Nerve issues, spinal issues, joint issues; Nerve issues, spinal issues, joint issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details), for Covid-19 immunization. The following information was reported: SPINAL CORD INJURY (disability, medically significant), NERVE INJURY (disability), JOINT INJURY (disability), outcome "unknown" and all described as "Nerve issues, spinal issues, joint issues". The event "nerve issues, spinal issues, joint issues", "nerve issues, spinal issues, joint issues" and "nerve issues, spinal issues, joint issues" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were not taken as a result of spinal cord injury, nerve injury, joint injury. The patient had no other vaccine in four weeks. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. The patient did not have Covid prior to vaccination, the patient was not tested for covid-19 post vaccination. If treatment ae: No The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient refers that He started to feel dizziness and loss of consciousness, was evaluated for paramedics who took her blood pressure having 80/50, Patient recovered, felt better and didn't wanted to go to the hospital.
Recieved flu injection 10/28, reaction 10/30 - Made an appointment for Dr. appt. Reaction measures 4" x 3.25" on the left deltoid Meds given - Diphenhydramine HCL 25MG Hydrocortisone 1# cream Ibuprofen 600mg
Within two weeks of receiving the first dose of the vaccine I had a fever and I felt terrible. The fever was around 102 and lasted two days. I had no sense of taste and smell for three days. I tested negative two times during that week. I had a family member who tested positive around the same time as I got the shot. I was prescribed antibiotics at the urgent care because my ear was inflamed. I was fully recovered after one week.  I got the second dose with no problems. Lot Number EL9262 I also visited Dr and my blood pressure and heart rate were elevated.
Pt vaccinated with MMR experienced pain, swelling, increased warmth & abscess formation at immunization site. 5 days after receiving MMR vaccine she was seen at the Hosp ER & the abscess was drained 30JUL90.
Myalgia, NauseaVomiting, Fatigue, Chills Narrative:
Within 24 hours of getting the first vaccine dose, my ears starting ringing and a feeling of pressure increased in my head/ears to an uncomfortable amount and made it hard to concentrate and to hear.  The effect is similar to being underwater - pressure filled head and muffled hearing.  The ringing continued for about 48 hours.  The pressure effect in my ears and head continued for several days.  It has come and gone over the last several months, lasting a few days at a time then waning for a few days before coming back and sometimes comes with mild pain in ears.  I thought it was possibly a new reaction to seasonal allergies that I just have never have experienced and started taking decongestant.  It gave a little relief however inconsistently.  I asked my primary care doctor at my annual appointment about it and she referred me to an ENT. Completed a physical exam and his office completed an audiology and pressure test.  Pressure in the ears was normal, however the audiology test showed hearing loss in my right ear.  Said that sudden hearing loss was likely due to a virus and pressure feeling came along with hearing loss.  The ear pain may be related to teeth grinding.
On march 7th 2021 I noticed many swollen lymph nodes on my left collarbone. I had the vaccine february 26th 2021. My lymph nodes in my left collarbone are still swollen today, although not painful, march 12th 2021. I am about to call my the and ask their advice.
Patient received the Pfizer COVID-19 vaccine on 3/11/21 and 4/1/21, so was fully vaccinated when they tested positive for COVID-19 on 8/18/21
pt recvd vax; by the time pt got home t was up to 103; pt's eyes rolled back & body tremble a little; mom states she was holding pt at this time & it happen for 8 seconds; called MD couple of days later; did not go to hosp;
Patient is a 82 y.o. left-handed male with hx of Afib on Eliquis, DM, HLD, HTN admitted after being found to be COVID positive and recent symptoms of diarrhea, malaise. Stroke activated due to aphasia, dysarthria of onset approximately 1415; patient was reportedly fluent in speech in the ED and noted on initial assessment after transfer to floor to be acutely aphasic. Patient reports taking Eliquis this morning. Acknowledges word finding difficulty, expresses frustration over this. Denies this ever happening before. Denies vision changes, facial weakness or sensory deficit, extremity weakness or sensory deficit.
15 years old received the Moderna COVID 19 vaccine.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 years old received the Moderna COVID 19 vaccine.) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 years old received the Moderna COVID 19 vaccine.). On 18-Nov-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 years old received the Moderna COVID 19 vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.; Sender's Comments: Non-serious Case